Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?

Nat Rev Nephrol. 2012 Nov;8(11):615-6. doi: 10.1038/nrneph.2012.219. Epub 2012 Oct 9.
No abstract available

Publication types

  • News

MeSH terms

  • Acetates / therapeutic use*
  • Blood Vessels / pathology
  • Calcinosis
  • Calcium Compounds / therapeutic use
  • Chelating Agents / therapeutic use*
  • Disease Progression
  • Humans
  • Hyperphosphatemia / etiology
  • Hyperphosphatemia / prevention & control
  • Lanthanum / therapeutic use*
  • Phosphate-Binding Proteins / metabolism
  • Phosphate-Binding Proteins / therapeutic use*
  • Phosphates / metabolism
  • Polyamines / therapeutic use*
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / drug therapy*
  • Renal Insufficiency, Chronic / metabolism
  • Renal Insufficiency, Chronic / physiopathology
  • Sevelamer

Substances

  • Acetates
  • Calcium Compounds
  • Chelating Agents
  • Phosphate-Binding Proteins
  • Phosphates
  • Polyamines
  • lanthanum carbonate
  • Lanthanum
  • Sevelamer
  • calcium acetate